Market Place
Sourcing Support
Predictive Oncology Restores Nasdaq Stockholders` Equity
02 Dec 2025 //
GLOBENEWSWIRE
Predictive Oncology Boosts Board And Leadership For Treasury
14 Oct 2025 //
GLOBENEWSWIRE
Predictive Oncology Closes $343.5M Private Placements
08 Oct 2025 //
GLOBENEWSWIRE
Predictive Oncology Initiates $344M Private Placements
29 Sep 2025 //
GLOBENEWSWIRE
Predictive Oncology Announces 1-For-15 Reverse Stock Split
25 Sep 2025 //
GLOBENEWSWIRE
Predictive Oncology, Every Cure Partner on Cancer Drugs
04 Sep 2025 //
GLOBENEWSWIRE
Predictive Oncology Plans US, EU ChemoFx®, AI-Driven Drug Launch
15 Jul 2025 //
GLOBENEWSWIRE
Court Denies Renovaro Motion for an Expedited Trial in July
27 May 2025 //
GLOBENEWSWIRE
Predictive Oncology Reports Q1 2025 Financial Results & Update
15 May 2025 //
GLOBENEWSWIRE
Predictive Oncology Develops New Approach for Abandoned Drugs
15 Apr 2025 //
GLOBENEWSWIRE
Predictive Oncology Reports 2024 Financials and Corporate Update
01 Apr 2025 //
GLOBENEWSWIRE
Predictive Oncology Sells Skyline Medical Assets to DeRoyal
20 Mar 2025 //
GLOBENEWSWIRE
Predictive Oncology Moves To Finalize Merger With Renovaro
03 Mar 2025 //
GLOBENEWSWIRE
Renovaro Completes Milestone Payment In Predictive Oncology Deal
03 Mar 2025 //
GLOBENEWSWIRE
Predictive Oncology Announces Direct Offering Under Nasdaq Rules
19 Feb 2025 //
GLOBENEWSWIRE
Predictive & Tecan Partner To Expand 3D Tumor Drug Screening
10 Feb 2025 //
GLOBENEWSWIRE
Predictive Oncology Announces Agreement to be Acquired by Renovaro
06 Jan 2025 //
GLOBENEWSWIRE
Predictive Oncology Reports Q3 2024 Results & Strategy
13 Nov 2024 //
GLOBENEWSWIRE
Predictive Oncology Study Shows Stability Of Proprietary Tumor Biobank
27 Aug 2024 //
GLOBENEWSWIRE
Predictive Oncology Reports Q2 2024 Financial Results And Business Update
14 Aug 2024 //
GLOBENEWSWIRE
Predictive Oncology Expands Live-Cell Platform For Drug Discovery
13 Aug 2024 //
GLOBENEWSWIRE
Predictive Oncology To Report Q2 2024 Results On August 14
07 Aug 2024 //
GLOBENEWSWIRE
Predictive Oncology Reports $1.26M Gross Proceeds From Warrant Exercise
26 Jul 2024 //
GLOBENEWSWIRE
Predictive Oncology Enters Biomarker Market Post Ovarian Cancer Study
25 Jul 2024 //
GLOBENEWSWIRE
Predictive Oncology Deve Novel Stem Cell Expression System for the Production
11 Jun 2024 //
GLOBENEWSWIRE
Predictive Oncology: 3D Cell Tech For Cancer Drug Discovery
04 Jun 2024 //
GLOBENEWSWIRE
Predictive Oncology Reports Q1 2024 Financials, Business Update
15 May 2024 //
GLOBENEWSWIRE
Predictive Oncology Q1 2024 Results On May 15
10 May 2024 //
GLOBENEWSWIRE
Predictive Oncology Reports Year End 2023 Financial Results
28 Mar 2024 //
GLOBENEWSWIRE
Predictive Oncology Reports Third Quarter 2023 Financial Results
14 Nov 2023 //
GLOBENEWSWIRE
Predictive Oncology to Report Third Quarter 2023 Financial Results
07 Nov 2023 //
GLOBENEWSWIRE
Predictive Oncology Reports Second Quarter 2023 Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh
18 Jul 2023 //
GLOBENEWSWIRE
Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr.Andrew Einhorn
27 Jun 2023 //
GLOBENEWSWIRE
Predictive Oncology invited to present approach to drug discovery at Convention
23 May 2023 //
GLOBENEWSWIRE
Predictive Oncology Reports 1Q 2023 FYR Results and Provides Business Update
15 May 2023 //
GLOBENEWSWIRE
Predictive Oncology to Report 1Q 2023 FYR and Host Conference Call
08 May 2023 //
GLOBENEWSWIRE
Predictive Oncology Announces Reverse Stock Split
20 Apr 2023 //
GLOBENEWSWIRE
Predictive Oncology Adjourns Special Meeting of Stockholders
17 Apr 2023 //
GLOBENEWSWIRE
Predictive Announces Appointment of Christoph Reinhard to Advisory Board
04 Apr 2023 //
GLOBENEWSWIRE
Predictive Reports Year End 2022 Financial Results and Provides Business Update
21 Mar 2023 //
GLOBENEWSWIRE
Predictive Oncology and Cancer Research Horizons have partnered
17 Mar 2023 //
GLOBENEWSWIRE
Predictive Announces Distribution of Series F Preferred Stock to Holders
16 Mar 2023 //
GLOBENEWSWIRE
Predictive Engages LifeSci Advisors as Strategic Investor Relations Partner
14 Mar 2023 //
GLOBENEWSWIRE
Predictive Oncology Issues Letter to Shareholders
09 Mar 2023 //
GLOBENEWSWIRE
Predictive Oncology launches ACE program to partner with institutions
21 Feb 2023 //
GLOBENEWSWIRE
Predictive Oncology Appoints Pamela Bush, Ph.D., MBA, as Chief Business Officer
03 Feb 2023 //
GLOBENEWSWIRE
Pioneer of Computational Biology Joins the Scientific Advisory Board
12 Jan 2023 //
GLOBENEWSWIRE
Innovator in Genomics Joins Scientific Advisory Board of Predictive Oncology
13 Dec 2022 //
GLOBENEWSWIRE
Predictive Oncology Appoints Matthew Hawryluk to the Board of Directors
05 Dec 2022 //
BIOSPACE
Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryl
05 Dec 2022 //
GLOBENEWSWIRE
David S. Smith appointed to the Board of Directors of Predictive Oncology
25 Oct 2022 //
GLOBENEWSWIRE
Predictive Oncology Announces New Chief Executive Officer Raymond F. Vennare
20 Oct 2022 //
GLOBENEWSWIRE
Predictive Oncology Strengthens Offerings with GMP Lab and Addition Expert
19 Sep 2022 //
GLOBENEWSWIRE
Predictive Oncology Announces CEO Retirement
16 Sep 2022 //
GLOBENEWSWIRE
Predictive Oncology Reports Second Quarter 2022 Financial Results
11 Aug 2022 //
GLOBENEWSWIRE
Predictive Oncology Strengthens Business with Appointment of CSO
26 Jul 2022 //
GLOBENEWSWIRE
Predictive Oncology Announces Closing of $7.2M Registered Direct Offerings
18 May 2022 //
GLOBENEWSWIRE
Predictive Oncology Announces $7.2 Million Registered Direct Offerings
16 May 2022 //
GLOBENEWSWIRE
Predictive Oncology Reports First Quarter Financial Results
12 May 2022 //
GLOBENEWSWIRE
